Brooks Laboratories Limited (BOM:533543)
67.30
0.00 (0.00%)
At close: Jun 19, 2026
Brooks Laboratories Revenue
In the fiscal year ending March 31, 2026, Brooks Laboratories had annual revenue of 857.38M INR with 3.85% growth. Brooks Laboratories had revenue of 202.10M in the quarter ending March 31, 2026, a decrease of -13.33%.
Revenue
857.38M
Revenue Growth
+3.85%
P/S Ratio
2.29
Revenue / Employee
2.65M
Employees
323
Market Cap
1.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 857.38M | 31.82M | 3.85% |
| Mar 31, 2025 | 825.57M | 30.71M | 3.86% |
| Mar 31, 2024 | 794.86M | 162.81M | 25.76% |
| Mar 31, 2023 | 632.05M | -279.80M | -30.69% |
| Mar 31, 2022 | 911.85M | 139.38M | 18.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.49B |
| Ambalal Sarabhai Enterprises | 2.02B |
| Sat Kartar Life | 2.01B |
| Gennex Laboratories | 1.73B |
| Kerala Ayurveda | 1.31B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |
| Coral Laboratories | 859.00M |